http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-0102320-D0
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3ec8c789965d20c3c9fa9118d9173b3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-03 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-03 |
| filingDate | 2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba38cdeb28cb1507d28f9106c14d44d7 |
| publicationDate | 2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SE-0102320-D0 |
| titleOfInvention | Novel treatment of adrenocortical hypersecretion and tumor growth |
| abstract | Chemical substances having selective adrenal toxicity for use in medicine, especially for treatment of adrenocortical hypersecretion and tumour growth. There is provided a compound having the following formula for use in medicine, especially human medicine wherein the first phenyl ring comprises one or more substituents R<SUB>1 </SUB>which is halogen (F, Cl, Br or I), preferably in position 4; R<SUB>2 </SUB>and R<SUB>3 </SUB>are halogen, A is a single or double bond between the side chain carbon atoms; the second phenyl ring comprises an electrophilic group R<SUB>4</SUB>, preferably in position 3, which is SO<SUB>2 </SUB>R<SUB>5 </SUB>or its metabolic precursors S R<SUB>5 </SUB>and SOR<SUB>5</SUB>, NO<SUB>2 </SUB>or CF<SUB>3</SUB>, where R<SUB>5 </SUB>is H or a lower alkyl, especially CH<SUB>3</SUB>; and one or more substituents R6 which is halogen (F, Cl, Br or I), preferably in position 4 |
| priorityDate | 2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.